LFTs are a panel of blood tests that help detect liver injury, cholestasis or synthetic dysfunction. Learn what each marker ...
Gilead Sciences, Inc. (Nasdaq: GILD) will present new research that reinforces its commitment to advancing innovation for ...
Obeticholic acid added to ursodeoxycholic acid improved alkaline phosphatase and bilirubin levels among patients with PBC unresponsive to first-line therapy.
Health Canada has granted conditional approval for Gilead Sciences’ Lyvdelzi (seladelpar) for adults with primary biliary ...
CNW/ - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Health Canada has approved LYVDELZI (seladelpar) for the ...
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies ...
Proqr Therapeutics NV has received clinical trial application (CTA) authorization under the EMA’s new centralized review ...
Morgan Stanley raised the firm’s price target on Mirum Pharmaceuticals (MIRM) to $81 from $75 and keeps an Overweight rating on the shares. For ...
MIRM's Livmarli remains its dominant growth engine and is expected to have boosted its top line in the third quarter.
MedPage Today on MSN
Diet Soda and Liver Risk; Pig-to-Human Liver Transplant; Golimumab Approval Expanded
The FDA expanded the approval of golimumab (Simponi) to include kids with moderately to severely active ulcerative colitis who weigh at least 15 kg (33 lb), Johnson & Johnson anno ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback